메뉴 건너뛰기




Volumn 237, Issue 1, 2014, Pages 5-12

A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease

(26)  Holmes, Michael V a,b   Frikke Schmidt, Ruth c,e,f   Melis, Daniela b   Luben, Robert g   Asselbergs, Folkert W b,h,i   Boer, Jolanda M A j   Cooper, Jackie b   Palmen, Jutta b   Horvat, Pia b   Engmann, Jorgen b   Li, Ka Wah b   Onland Moret, N Charlotte h   Hofker, Marten H k   Kumari, Meena b   Keating, Brendan J a   Hubacek, Jaroslav A l   Adamkova, Vera l   Kubinova, Ruzena m   Bobak, Martin b   Khaw, Kay Tee g   more..


Author keywords

APOE genotype; Coronary heart disease; Gene environment interaction; Smoking

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CARRIER PROTEIN;

EID: 84907695230     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.038     Document Type: Article
Times cited : (25)

References (30)
  • 1
    • 84871055775 scopus 로고    scopus 로고
    • Acomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
    • Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H., et al. Acomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2224-2260.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2224-2260
    • Lim, S.S.1    Vos, T.2    Flaxman, A.D.3    Danaei, G.4    Shibuya, K.5    Adair-Rohani, H.6
  • 2
    • 0024299370 scopus 로고
    • Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
    • Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240(4852):622-630.
    • (1988) Science , vol.240 , Issue.4852 , pp. 622-630
    • Mahley, R.W.1
  • 3
    • 52949152370 scopus 로고    scopus 로고
    • ApoE genotype: impact on health, fitness and nutrition
    • Angelopoulos T.J., Lowndes J. ApoE genotype: impact on health, fitness and nutrition. World Rev Nutr Diet 2008, 98:77-93.
    • (2008) World Rev Nutr Diet , vol.98 , pp. 77-93
    • Angelopoulos, T.J.1    Lowndes, J.2
  • 4
    • 34548736492 scopus 로고    scopus 로고
    • Association of apolipoprotein E genotypes with lipid levels and coronary risk
    • Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298(11):1300-1311.
    • (2007) JAMA , vol.298 , Issue.11 , pp. 1300-1311
    • Bennet, A.M.1    Di Angelantonio, E.2    Ye, Z.3    Wensley, F.4    Dahlin, A.5    Ahlbom, A.6
  • 5
    • 0036218156 scopus 로고    scopus 로고
    • Molecular biology of apolipoprotein E
    • Strittmatter W.J., Bova Hill C. Molecular biology of apolipoprotein E. Curr Opin Lipidol 2002, 13(2):119-123.
    • (2002) Curr Opin Lipidol , vol.13 , Issue.2 , pp. 119-123
    • Strittmatter, W.J.1    Bova Hill, C.2
  • 6
    • 0035859488 scopus 로고    scopus 로고
    • Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
    • Humphries S.E., Talmud P.J., Hawe E., Bolla M., Day I.N., Miller G.J. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001, 358(9276):115-119.
    • (2001) Lancet , vol.358 , Issue.9276 , pp. 115-119
    • Humphries, S.E.1    Talmud, P.J.2    Hawe, E.3    Bolla, M.4    Day, I.N.5    Miller, G.J.6
  • 7
    • 0037309833 scopus 로고    scopus 로고
    • Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E 2/3/4 genotype
    • Keavney B., Parish S., Palmer A., Clark S., Youngman L., Danesh J., et al. Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E 2/3/4 genotype. Lancet 2003, 361(9355):396-398.
    • (2003) Lancet , vol.361 , Issue.9355 , pp. 396-398
    • Keavney, B.1    Parish, S.2    Palmer, A.3    Clark, S.4    Youngman, L.5    Danesh, J.6
  • 8
    • 84877265172 scopus 로고    scopus 로고
    • Smoking, apolipoprotein E genotypes, and mortality (the Ludwigshafen RIsk and Cardiovascular Health study)
    • Grammer T.B., Hoffmann M.M., Scharnagl H., Kleber M.E., Silbernagel G., Pilz S., et al. Smoking, apolipoprotein E genotypes, and mortality (the Ludwigshafen RIsk and Cardiovascular Health study). Eur Heart J 2013, 34(17):1298-1305.
    • (2013) Eur Heart J , vol.34 , Issue.17 , pp. 1298-1305
    • Grammer, T.B.1    Hoffmann, M.M.2    Scharnagl, H.3    Kleber, M.E.4    Silbernagel, G.5    Pilz, S.6
  • 9
    • 84855961434 scopus 로고    scopus 로고
    • Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women
    • Gustavsson J., Mehlig K., Leander K., Strandhagen E., Bjorck L., Thelle D.S., et al. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis 2012, 220(2):486-492.
    • (2012) Atherosclerosis , vol.220 , Issue.2 , pp. 486-492
    • Gustavsson, J.1    Mehlig, K.2    Leander, K.3    Strandhagen, E.4    Bjorck, L.5    Thelle, D.S.6
  • 11
    • 84873344743 scopus 로고    scopus 로고
    • Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials
    • Myung S.K., Ju W., Cho B., Oh S.W., Park S.M., Koo B.K., et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 346:f10.
    • (2013) BMJ , vol.346 , pp. f10
    • Myung, S.K.1    Ju, W.2    Cho, B.3    Oh, S.W.4    Park, S.M.5    Koo, B.K.6
  • 12
    • 68049122102 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    • Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097.
    • (2009) PLoS Med , vol.6 , Issue.7 , pp. e1000097
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4    Group, P.5
  • 13
    • 0023751492 scopus 로고
    • Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study
    • Meade T.W., Wilkes H.C., Stirling Y., Brennan P.J., Kelleher C., Browne W. Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study. Eur Heart J 1988, 9(8):836-843.
    • (1988) Eur Heart J , vol.9 , Issue.8 , pp. 836-843
    • Meade, T.W.1    Wilkes, H.C.2    Stirling, Y.3    Brennan, P.J.4    Kelleher, C.5    Browne, W.6
  • 15
    • 33645236035 scopus 로고    scopus 로고
    • Quality of life at older ages: evidence from the English longitudinal study of aging (wave 1)
    • Netuveli G., Wiggins R.D., Hildon Z., Montgomery S.M., Blane D. Quality of life at older ages: evidence from the English longitudinal study of aging (wave 1). JEpidemiol Commun Health 2006, 60(4):357-363.
    • (2006) JEpidemiol Commun Health , vol.60 , Issue.4 , pp. 357-363
    • Netuveli, G.1    Wiggins, R.D.2    Hildon, Z.3    Montgomery, S.M.4    Blane, D.5
  • 17
    • 34447511196 scopus 로고    scopus 로고
    • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
    • Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298(3):299-308.
    • (2007) JAMA , vol.298 , Issue.3 , pp. 299-308
    • Nordestgaard, B.G.1    Benn, M.2    Schnohr, P.3    Tybjaerg-Hansen, A.4
  • 18
    • 77955277014 scopus 로고    scopus 로고
    • Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA
    • Cifkova R., Skodova Z., Bruthans J., Adamkova V., Jozifova M., Galovcova M., et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 2010, 211(2):676-681.
    • (2010) Atherosclerosis , vol.211 , Issue.2 , pp. 676-681
    • Cifkova, R.1    Skodova, Z.2    Bruthans, J.3    Adamkova, V.4    Jozifova, M.5    Galovcova, M.6
  • 19
    • 0032795012 scopus 로고    scopus 로고
    • EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer
    • Day N., Oakes S., Luben R., Khaw K.T., Bingham S., Welch A., et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999, 80(Suppl.1):95-103.
    • (1999) Br J Cancer , vol.80 , Issue.SUPPL.1 , pp. 95-103
    • Day, N.1    Oakes, S.2    Luben, R.3    Khaw, K.T.4    Bingham, S.5    Welch, A.6
  • 20
    • 33750557199 scopus 로고    scopus 로고
    • Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study
    • Peasey A., Bobak M., Kubinova R., Malyutina S., Pajak A., Tamosiunas A., et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006, 6:255.
    • (2006) BMC Public Health , vol.6 , pp. 255
    • Peasey, A.1    Bobak, M.2    Kubinova, R.3    Malyutina, S.4    Pajak, A.5    Tamosiunas, A.6
  • 21
    • 0036094580 scopus 로고    scopus 로고
    • Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype
    • Lussier-Cacan S., Bolduc A., Xhignesse M., Niyonsenga T., Sing C.F. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype. Arteriosclerosis Thromb Vascu Biol 2002, 22(5):824-831.
    • (2002) Arteriosclerosis Thromb Vascu Biol , vol.22 , Issue.5 , pp. 824-831
    • Lussier-Cacan, S.1    Bolduc, A.2    Xhignesse, M.3    Niyonsenga, T.4    Sing, C.F.5
  • 22
    • 4344634312 scopus 로고    scopus 로고
    • Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: implications for association analyses
    • Chen X.H., Rodriguez S., Hawe E., Talmud P.J., Miller G.J., Underhill P., et al. Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: implications for association analyses. Human Heredity 2004, 57(3):142-155.
    • (2004) Human Heredity , vol.57 , Issue.3 , pp. 142-155
    • Chen, X.H.1    Rodriguez, S.2    Hawe, E.3    Talmud, P.J.4    Miller, G.J.5    Underhill, P.6
  • 23
    • 0037299527 scopus 로고    scopus 로고
    • Aprospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men
    • Liu S., Ma J., Ridker P.M., Breslow J.L., Stampfer M.J. Aprospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. Atherosclerosis 2003, 166(2):323-329.
    • (2003) Atherosclerosis , vol.166 , Issue.2 , pp. 323-329
    • Liu, S.1    Ma, J.2    Ridker, P.M.3    Breslow, J.L.4    Stampfer, M.J.5
  • 24
    • 5444255051 scopus 로고    scopus 로고
    • No APOE4 effect on coronary heart disease risk in a cohort with low smoking prevalence: The Whitehall II study
    • Talmud P.J., Lewis S.J., Hawe E., Martin S., Acharya J., Marmot M.G., et al. No APOE4 effect on coronary heart disease risk in a cohort with low smoking prevalence: The Whitehall II study. Atherosclerosis 2004, 177(1):105-112.
    • (2004) Atherosclerosis , vol.177 , Issue.1 , pp. 105-112
    • Talmud, P.J.1    Lewis, S.J.2    Hawe, E.3    Martin, S.4    Acharya, J.5    Marmot, M.G.6
  • 25
    • 0025737883 scopus 로고
    • Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials
    • Yusuf S., Wittes J., Probstfield J., Tyroler H.A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991, 266(1):93-98.
    • (1991) JAMA , vol.266 , Issue.1 , pp. 93-98
    • Yusuf, S.1    Wittes, J.2    Probstfield, J.3    Tyroler, H.A.4
  • 26
    • 28244453652 scopus 로고    scopus 로고
    • Nature's randomised trials
    • Hingorani A., Humphries S. Nature's randomised trials. Lancet 2005, 366(9501):1906-1908.
    • (2005) Lancet , vol.366 , Issue.9501 , pp. 1906-1908
    • Hingorani, A.1    Humphries, S.2
  • 27
    • 0034466679 scopus 로고    scopus 로고
    • Debate: subgroup analyses in clinical trials: fun to look at - but don't believe them!
    • Sleight P. Debate: subgroup analyses in clinical trials: fun to look at - but don't believe them!. Curr Control Trials Cardiovasc Med 2000, 1(1):25-27.
    • (2000) Curr Control Trials Cardiovasc Med , vol.1 , Issue.1 , pp. 25-27
    • Sleight, P.1
  • 28
    • 55949084294 scopus 로고    scopus 로고
    • Why current publication practices may distort science
    • Young N.S., Ioannidis J.P., Al-Ubaydli O. Why current publication practices may distort science. PLoS Med 2008, 5(10):e201.
    • (2008) PLoS Med , vol.5 , Issue.10 , pp. e201
    • Young, N.S.1    Ioannidis, J.P.2    Al-Ubaydli, O.3
  • 29
    • 84870944183 scopus 로고    scopus 로고
    • From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer
    • Willke R.J., Zheng Z., Subedi P., Althin R., Mullins C.D. From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer. BMC Med Res Methodol 2012, 12:185.
    • (2012) BMC Med Res Methodol , vol.12 , pp. 185
    • Willke, R.J.1    Zheng, Z.2    Subedi, P.3    Althin, R.4    Mullins, C.D.5
  • 30
    • 0032562005 scopus 로고    scopus 로고
    • Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework
    • Thrombosis prevention trial
    • Thrombosis prevention trial randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998, 351(9098):233-241.
    • (1998) Lancet , vol.351 , Issue.9098 , pp. 233-241


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.